Physician profile
Diego Ramirez
NPI 1639513161
$6,464.29
in general payments reported to CMS, 2019-2025
25 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,432 · 2020: $243 · 2021: $1,187 · 2022: $456 · 2023: $703 · 2024: $159 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,199.57 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $730.83 | 2019-2023 | |
| Coloplast Corp | $686.23 | 2021-2023 | Saffron |
| Avion Pharmaceuticals | $223.78 | 2019-2023 | Balcoltra |
| Organon LLC | $157.91 | 2021-2025 | Nexplanon |
| Coopersurgical, INC. | $157.38 | 2021-2025 | Paragard T 380a |
| Shield Therapeutics INC | $155.60 | 2023-2025 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $143.26 | 2019-2025 | |
| Exeltis, USA INC. | $137.72 | 2019-2025 | Slynd |
| Pacira Pharmaceuticals Incorporated | $121.87 | 2019 | |
| Genmab U.S., INC. | $95.40 | 2022 | |
| Daiichi Sankyo INC. | $94.19 | 2022 | |
| Avanos Medical | $90.95 | 2021-2025 | On-Q Pump and Accessories |
| Vertical Pharmaceuticals, LLC | $79.41 | 2019 | |
| Astellas Pharma US INC | $68.27 | 2023-2024 | Veozah |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $59.45 | 2022-2023 | |
| Pfizer INC. | $55.72 | 2021-2025 | |
| Therapeuticsmd, INC. | $44.66 | 2021-2022 | |
| Acessa Health INC. | $43.47 | 2019 | |
| Hologic Sales and Service, LLC | $37.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $24.44 | 2021 | |
| Scynexis, INC. | $17.10 | 2022 | |
| Mission Pharmacal Company | $15.89 | 2021 | |
| Medtronic, INC. | $15.34 | 2024 | V-Loc 180 |
| Alydia Health | $8.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.